NO20050088L - Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav - Google Patents
Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse deravInfo
- Publication number
- NO20050088L NO20050088L NO20050088A NO20050088A NO20050088L NO 20050088 L NO20050088 L NO 20050088L NO 20050088 A NO20050088 A NO 20050088A NO 20050088 A NO20050088 A NO 20050088A NO 20050088 L NO20050088 L NO 20050088L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- diphenylazofidinones
- processes
- preparation
- medicaments containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Det er beskrevet forbindelser med formel I, hvori RI, R2, R3, R4, R5 og R6 har de angitte betydningene, samt deres fysiologisk godtagbare salter. Forbindelsene egner seg for eksempel som hypolipidemika.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10227507A DE10227507A1 (de) | 2002-06-19 | 2002-06-19 | Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
PCT/EP2003/005814 WO2004000803A1 (de) | 2002-06-19 | 2003-06-04 | Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050088L true NO20050088L (no) | 2005-01-06 |
Family
ID=29719282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050088A NO20050088L (no) | 2002-06-19 | 2005-01-06 | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1517890B1 (no) |
JP (1) | JP2005533071A (no) |
KR (1) | KR20050010061A (no) |
CN (1) | CN1662494A (no) |
AT (1) | ATE401304T1 (no) |
AU (1) | AU2003238209B2 (no) |
BR (1) | BR0311984A (no) |
CA (1) | CA2490108A1 (no) |
DE (2) | DE10227507A1 (no) |
DK (1) | DK1517890T3 (no) |
ES (1) | ES2310662T3 (no) |
HR (1) | HRP20041202A2 (no) |
IL (1) | IL165790A (no) |
MA (1) | MA27251A1 (no) |
MX (1) | MXPA04012308A (no) |
NO (1) | NO20050088L (no) |
PA (1) | PA8575601A1 (no) |
PL (1) | PL372660A1 (no) |
PT (1) | PT1517890E (no) |
RS (1) | RS108604A (no) |
RU (1) | RU2315753C2 (no) |
SV (1) | SV2004001555A (no) |
TW (1) | TW200406380A (no) |
UY (1) | UY27852A1 (no) |
WO (1) | WO2004000803A1 (no) |
ZA (1) | ZA200409379B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
EP1699759B1 (en) | 2003-12-23 | 2010-10-20 | AstraZeneca AB | Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
NZ555320A (en) | 2004-12-03 | 2010-11-26 | Schering Corp | Substituted piperazines as CB1 antagonists |
MX2007012253A (es) | 2005-04-04 | 2007-12-07 | Univ Pontificia Catolica Chile | Uso de ezetimibe para la prevencion y tratamiento de calculos de colesterol en la via biliar. |
CN101243072A (zh) | 2005-06-20 | 2008-08-13 | 先灵公司 | 用作组胺h3拮抗剂的哌啶衍生物 |
SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
DE102007002260A1 (de) | 2007-01-16 | 2008-07-31 | Sanofi-Aventis | Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2010100255A1 (en) | 2009-03-06 | 2010-09-10 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
CN101993403B (zh) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
ES2443016T3 (es) | 2009-08-26 | 2014-02-17 | Sanofi | Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042447A1 (de) * | 2000-08-29 | 2002-03-28 | Aventis Pharma Gmbh | Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports |
AU2002231688A1 (en) * | 2000-12-21 | 2002-07-01 | Sanofi-Aventis Deutschland Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
IL156552A0 (en) * | 2000-12-21 | 2004-01-04 | Aventis Pharma Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
MXPA03005155A (es) * | 2000-12-21 | 2003-09-10 | Aventis Pharma Gmbh | 1,2-difenilazetidinonas novedosas, procesos para su preparacion, farmacos que contienen compuestos y su uso para el tratamiento del metabolismo afectado de los lipidos. |
-
2002
- 2002-06-19 DE DE10227507A patent/DE10227507A1/de not_active Withdrawn
-
2003
- 2003-06-04 RU RU2005101088/04A patent/RU2315753C2/ru not_active IP Right Cessation
- 2003-06-04 ES ES03735534T patent/ES2310662T3/es not_active Expired - Lifetime
- 2003-06-04 DE DE50310161T patent/DE50310161D1/de not_active Expired - Lifetime
- 2003-06-04 CA CA002490108A patent/CA2490108A1/en not_active Abandoned
- 2003-06-04 EP EP03735534A patent/EP1517890B1/de not_active Expired - Lifetime
- 2003-06-04 JP JP2004514659A patent/JP2005533071A/ja not_active Abandoned
- 2003-06-04 AT AT03735534T patent/ATE401304T1/de not_active IP Right Cessation
- 2003-06-04 PL PL03372660A patent/PL372660A1/xx not_active Application Discontinuation
- 2003-06-04 DK DK03735534T patent/DK1517890T3/da active
- 2003-06-04 MX MXPA04012308A patent/MXPA04012308A/es active IP Right Grant
- 2003-06-04 AU AU2003238209A patent/AU2003238209B2/en not_active Ceased
- 2003-06-04 WO PCT/EP2003/005814 patent/WO2004000803A1/de active IP Right Grant
- 2003-06-04 KR KR10-2004-7020518A patent/KR20050010061A/ko not_active Application Discontinuation
- 2003-06-04 PT PT03735534T patent/PT1517890E/pt unknown
- 2003-06-04 BR BR0311984-0A patent/BR0311984A/pt not_active IP Right Cessation
- 2003-06-04 RS YUP-1086/04A patent/RS108604A/sr unknown
- 2003-06-04 CN CN038140934A patent/CN1662494A/zh active Pending
- 2003-06-13 PA PA20038575601A patent/PA8575601A1/es unknown
- 2003-06-16 SV SV2003001555A patent/SV2004001555A/es unknown
- 2003-06-16 UY UY27852A patent/UY27852A1/es unknown
- 2003-06-17 TW TW092116320A patent/TW200406380A/zh unknown
-
2004
- 2004-11-22 ZA ZA200409379A patent/ZA200409379B/xx unknown
- 2004-12-08 MA MA27989A patent/MA27251A1/fr unknown
- 2004-12-15 IL IL165790A patent/IL165790A/en not_active IP Right Cessation
- 2004-12-17 HR HR20041202A patent/HRP20041202A2/xx not_active Application Discontinuation
-
2005
- 2005-01-06 NO NO20050088A patent/NO20050088L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HRP20041202A2 (en) | 2005-06-30 |
CN1662494A (zh) | 2005-08-31 |
CA2490108A1 (en) | 2003-12-31 |
ATE401304T1 (de) | 2008-08-15 |
IL165790A0 (en) | 2006-01-15 |
RS108604A (en) | 2007-02-05 |
UY27852A1 (es) | 2003-12-31 |
ES2310662T3 (es) | 2009-01-16 |
PT1517890E (pt) | 2008-10-14 |
PA8575601A1 (es) | 2004-02-07 |
KR20050010061A (ko) | 2005-01-26 |
EP1517890A1 (de) | 2005-03-30 |
SV2004001555A (es) | 2004-03-19 |
AU2003238209B2 (en) | 2009-01-22 |
IL165790A (en) | 2010-04-15 |
PL372660A1 (en) | 2005-07-25 |
WO2004000803A1 (de) | 2003-12-31 |
ZA200409379B (en) | 2006-05-31 |
TW200406380A (en) | 2004-05-01 |
MA27251A1 (fr) | 2005-03-01 |
JP2005533071A (ja) | 2005-11-04 |
AU2003238209A1 (en) | 2004-01-06 |
RU2005101088A (ru) | 2005-06-27 |
EP1517890B1 (de) | 2008-07-16 |
DK1517890T3 (da) | 2008-11-10 |
MXPA04012308A (es) | 2005-02-25 |
RU2315753C2 (ru) | 2008-01-27 |
DE10227507A1 (de) | 2004-01-08 |
DE50310161D1 (de) | 2008-08-28 |
BR0311984A (pt) | 2005-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
SE0301700D0 (sv) | Novel compounds | |
SE0202133D0 (sv) | Novel compounds | |
SE0200920D0 (sv) | Novel compounds | |
SE0104140D0 (sv) | Novel Compounds | |
NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
NO20062677L (no) | Benzyleteraminforbindelser anvendbare som CCR-5-antagonister | |
SE0302811D0 (sv) | Novel compounds | |
SE0102438D0 (sv) | New compounds | |
SE0401762D0 (sv) | Novel compounds | |
WO2006100081A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
IS2376B (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
EA200801011A1 (ru) | Производные пиразина как модуляторы натриевых каналов для лечения боли | |
TNSN04250A1 (en) | Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof. | |
MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
SE0302139D0 (sv) | Novel compounds | |
NO20062900L (no) | Nye forbindelser | |
SE0303541D0 (sv) | New compounds | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |